Motor Neurone Disease Trial, Recruiting (NCT04868994)

Motor Neurone Disease Trial, Recruiting NCT04868994 Sponsor: University Hospital, Toulouse Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04868994 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have signed a consent form agreeing to take part in the study
You have been assessed by doctors and are suspected to have ALS (also known as Lou Gehrig's disease or motor neurone disease), based on recognised diagnostic guidelines
A doctor has found signs of damage to the upper motor nerves (the nerves in your brain and spinal cord that send signals to muscles)
A nerve conduction or electrical test has shown signs of damage to the lower motor nerves (the nerves that directly connect to your muscles)

Who may not be able to join:

You are not able to give your own informed consent to take part
You have a medical reason why you cannot have an MRI scan (for example, a metal implant or pacemaker)
You have breathing difficulties that make it impossible for you to lie flat inside an MRI scanner
You are under a court-ordered protection arrangement or similar legal protective regime (confirm with trial site)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pascal CINTAS, MD, University Hospital, Toulouse

Phone: 05 61 77 94 40

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04868994

Sponsor: University Hospital, Toulouse

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: 05 61 77 94 40

More information: https://clinicaltrials.gov/study/NCT04868994

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have signed a consent form agreeing to take part in the study
You have been assessed by doctors and are suspected to have ALS (also known as Lou Gehrig's disease or motor neurone disease), based on recognised diagnostic guidelines
A doctor has found signs of damage to the upper motor nerves (the nerves in your brain and spinal cord that send signals to muscles)
A nerve conduction or electrical test has shown signs of damage to the lower motor nerves (the nerves that directly connect to your muscles)

Who may not be able to join:

You are not able to give your own informed consent to take part
You have a medical reason why you cannot have an MRI scan (for example, a metal implant or pacemaker)
You have breathing difficulties that make it impossible for you to lie flat inside an MRI scanner
You are under a court-ordered protection arrangement or similar legal protective regime (confirm with trial site)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Toulouse

Registry

ClinicalTrials.gov

Start date

1 June 2021

Est. completion

1 December 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Diagnostic certainty 1.ENMG according to El Escorial revised criteria using ENMG alone, MRI alone and ENMG+MRI to define denervation diffusion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov